Novo-Nordisk A/S (NVO) Ownership - Who owns Novo-Nordisk A/S?
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVO showed earnings on February 03, 2026. You can read more about the earnings report here.